Xpect Ibuprofen Tablet
Product Images NDC 42961-203

2 FDA label images from Cintas Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xpect Ibuprofen (NDC 42961-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cintas Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box50packets (Box50packets)

Box50packets (Box50packets)
Label for Xpect Ibuprofen 200 mg tablets, an oral pain reliever and fever reducer NSAID by Cintas Corporation. The label highlights full strength ibuprofen as the active ingredient, emphasizing temporary relief from pain, fever, and arthritis inflammation with an aspirin-free formula. The package contains 100 tablets divided into 50 packets, each with 2 tablets, and is marked as workplace ready with single dose and tamper evident features.*
FDA Label Image

Box125packets (Box125packets)

Box125packets (Box125packets)
Xpect Ibuprofen full strength 200 mg oral tablets packaging label. Features include Ibuprofen as the active ingredient, described as a pain reliever and fever reducer (NSAID) with aspirin-free formula. The label highlights temporary relief from pain, fever, and arthritis inflammation. It promotes workplace readiness with single dose and tamper-evident packaging. Pack contains 250 tablets in 125 packets, with 2 tablets per packet. Labeler is Cintas Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.